MovingWaterTopTraders

PREDICTION 3 #IONS - NASDAQ - SELL! UP TO 14% PROFIT!

Short
NASDAQ:IONS   IONIS PHARMACEUTICALS INC
Hi Followers,

Welcome to my page,

I will be posting 10 charts on USA #STOCK #MARKET this month. #STOCKMARKET

Using a Unique Technical Analysis invented by me.

Later, if the charts work out, I will talk more about it.

As far as our technical Analysis is identifying, there is a big possibility that this company is OVERBOUGHT, which opens a trade opportunity.

This could lead allow up to 14% profit and could end in 20 days.

About the Company: #IONS - #NASDAQ
Ionis Pharmaceuticals , Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy ( SMA ) in pediatric and adult patients; and TEGSEDI, an injection for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults. It is involved in developing neurology products that include IONIS-HTTRx for Huntington's diseases; and IONIS-SOD1Rx and IONIS-C9Rx for amyotrophic lateral sclerosis and IONIS-MAPTRx for Alzheimer's diseases. The company is also developing severe and rare disease products, such as WAYLIVRA, a treatment for familial chylomicronemia syndrome; WAYLIVRA, a treatment for familial partial lipodystrophy; AKCEA-TTR-LRx for transthyretin amyloidosis and IONIS-GHR-LRx for acromegaly; and IONIS-TMPRSS6-LRx for beta-thalassemia and iron toxicity, IONIS-PKKRx/IONIS-PKK-LRx for hereditary angioedema, and IONIS-ENAC-2.5Rx for cystic fibrosis. In addition, its cardiometabolic and renal drugs include AKCEA-ANGPTL3-LRx for cardiometabolic disorders, IONIS-FXIRx for clotting disorders, AKCEA-APO(a)-LRx and AKCEA-APOCIII-LRx for cardiovascular diseases, and IONIS-DGAT2Rx for nonalcoholic steatohepatitis; IONIS-AGT-LRX for the treatment of resistant hypertension; and IONIS-FXI-LRx for clotting disorders and IONIS-AZ4-2.5-LRx for cardiovascular diseases. Further, the company develops products for oncology that include IONIS-AR-2.5Rx and danvatirsen for cancers; and IONIS-HBVRx and IONIS-HBV-LRx for hepatitis b virus infection, and IONIS-FB-LRx for compliment meditated disease and IONIS-JBI1-2.5Rx for gastrointestinal autoimmune diseases. Ionis Pharmaceuticals , Inc. was founded in 1989 and is based in Carlsbad, California.

Good Luck and Good Profit

Trade active: If you want, you could Close Trade Now at:

6,50% PROFIT.

It should keep going.

Thank you for trusting and following.

Comments

Home Stock Screener Forex Screener Crypto Screener Economic Calendar How It Works Chart Features Pricing Refer a friend House Rules Help Center Website & Broker Solutions Widgets Charting Solutions Lightweight Charting Library Blog & News Twitter
Profile Profile Settings Account and Billing Referred friends Coins My Support Tickets Help Center Ideas Published Followers Following Private Messages Chat Sign Out